| 2007-09-28 |
Jane Emerson, M.D., Ph.D., 53, Director. Compensation: $11,632 from stock option awards. |
| 2008-09-29 |
Jane Emerson, M.D., Ph.D., 54, Director. Compensation: No direct payment, no options granted. |
| 2009-09-29 |
Jane Emerson, M.D., Ph.D. 55 2007 Director
Dr. Emerson has served as a director of the Company since April 2007.
DIRECTOR COMPENSATION
Jane Emerson, M.D., Ph.D. -0- -0- 4,819 -0- -0- -0- -0- -0- 4819 |
| 2010-09-29 |
Dr. Emerson has served as a director of the Company since April 2007. ... DIRECTOR COMPENSATION ... Jane Emerson, M.D., Ph.D. Option Awards ($) 3,677 Change in Pension Value and Nonqualified Deferred Compensation Earnings ($) -10,000 Total ($) -6,323 |
| 2011-09-28 |
Dr. Emerson has served as a director of the Company since April 2007. ... The following table presents the compensation of Non-Employee Directors for the fiscal year ended May 31, 2011. ... Jane Emerson, M.D., Ph.D. Fees Earned or Paid in Cash ($) -0- Option Awards ($) 7,672 All Other Compensation ($) -10,000- Total ($) 17,672 |
| 2012-09-28 |
Jane Emerson, M.D., Ph.D. 58 2007 Director
... The following table presents the compensation of Non-Employee Directors for the fiscal year ended May 31, 2012.
Name Fees Earned or Paid in Cash ($) Stock Awards ($) Option Awards ($) Non-Equity Incentive Plan Compensation ($) Change in Pension Value and Nonqualified Deferred Compensation Earnings All Other Compensation ($) Total ($)
Jane Emerson, M.D., Ph.D. -0- -0- 6,661 -0- -0- -10,000-(3) 16,661 |
| 2013-09-30 |
Dr. Emerson has served as a Director of the Company since April 2007. ... The following table presents the compensation of Non-Employee Directors for the fiscal year ended May 31, 2013. ... Jane Emerson, M.D., Ph.D. Fees Earned or Paid in Cash ($) -0- All Other Compensation ($) 10,000 Total ($) 10,000. Dr. Emerson received compensation for performance of certain consulting work for the Company. |
| 2014-09-29 |
Dr. Emerson has served as a Director of the Company since April 2007. Dr. Emerson received compensation for performance of certain consulting work for the Company. |
| 2015-09-28 |
Jane Emerson, M.D., Ph.D., 61, Director. Director compensation: $34,599 in 2015, including $10,000 for consulting work. |
| 2016-09-28 |
Jane Emerson, M.D., Ph.D. 62 2007 Director, Member of Audit Committee ... The following table presents the compensation of Non-Employee Directors for the fiscal year ended May 31, 2016 ... Jane Emerson, M.D., Ph.D. Fees Earned or Paid in Cash ($) -0- Option Awards ($) 15,225 All Other Compensation ($) 10,000 Total ($) 25,225 |
| 2017-09-28 |
Jane Emerson, M.D., Ph.D., 63, Director, Member of Audit Committee. Received $10,000 in other compensation in 2017. |
| 2018-09-28 |
Jane Emerson, M.D., Ph.D., 64, Director, Member of Audit Committee. Total compensation for fiscal 2018 was $60,293. |
| 2019-09-24 |
The following table sets forth the name and current age of each nominee for director, the year he or she was first elected a director and his or her position(s) with the Company. The Company does not pay a fee to any third party to identify potential nominees. The Board has not received recommended nominees from a stockholder. | Name | Age | Director Since | Positions Held | | Jane Emerson, M.D., Ph.D. | 65 | 2007 | Director, Member of Audit Committee | ... Although not prohibited by the Company's Bylaws, directors receive no cash compensation for their services as directors, but they have been, and may in the future be, granted options to purchase the Company's securities which serves as compensation for their services. The compensation of directors is subject to review and adjustment from time to time by the Board of Directors. The following table presents the compensation of Non-Employee Directors for the fiscal year ended May 31, 2019. - 10 - DIRECTOR COMPENSATION Although not prohibited by the Company's Bylaws, directors receive no cash compensation for their services as directors, but they have been, and may in the future be, granted options to purchase the Company's securities which serves as compensation for their services. The compensation of directors is subject to review and adjustment from time to time by the Board of Directors. The following table presents the compensation of Non-Employee Directors for the fiscal year ended May 31, 2019. - 10 - DIRECTOR COMPENSATION | Name | Fees Earned or Paid in Cash ($) | Stock Awards ($) | Option Awards ($) | Non-Equity Incentive Plan Compensation ($) | Change in Pension Value and Nonqualified Deferred Compensation Earnings | All Other Compensation ($) | Total ($) | | Jane Emerson, M.D., Ph.D. | -0- | -0- | 42,770 | -0- | -0- | 10,000 | 52,770 | ... (1) All outside directors each received a 35,000 share stock option grant in fiscal 2019 except for Allen Barbieri, who received a 50,000 share stock option grant. The options were granted at the exercise price of $2.25 per share (market value on the date of grant). The grants for 35,000 were valued at $42,770 and the option for 50,000 was valued at $61,100 using the Black-Scholes options-pricing model (which uses assumptions for expected volatility, expected dividends, expected forfeiture rate, expected term and the risk-free interest rate).
| 2020-09-25 |
Jane Emerson, M.D., Ph.D., 66, Director, Member of Audit Committee and Member of Compensation Committee and Nominating and Corporate Governance Committee. Compensation: $56,020 in fiscal 2020. |
| 2021-09-28 |
The following table sets forth the name and current age of each nominee for director, the year he or she was first elected a director and his or her position(s) with the Company... Jane Emerson, M.D., Ph.D. 67 2007 Director, Member of Audit Committee,Compensation Committee, NominatingAnd Corporate Governance Committee... The following table presents the compensation of Non-Employee Directors for the fiscal year ended May 31, 2021... Jane Emerson, M.D., Ph.D. Fees Earned or Paid in Cash ($) 26,250 Stock Awards ($) 0 Option Awards Value ($) 101,160 All Other Compensation ($) 10,000 Total Value ($) 137,410 |
| 2022-09-27 |
Dr. Jane Emerson has served as a Director of the Company since April 2007. ... For the fiscal year ended May 31, 2022, the Committee consisted of Dr. Jane Emerson, Dr. Mark Sirgo and Ms. Catherine Coste, with Dr. Jane Emerson serving as Chairperson of the Governance Committee. ... The Compensation Committee was comprised of Dr. Mark Sirgo, Dr. Jane Emerson and Ms. Catherine Coste, with Dr. Mark Sirgo serving as Chairperson of the Compensation Committee. It is anticipated that Dr. Jane Emerson will continue to serve on the Compensation Committee after the Annual Meeting. ... The Audit Committee consisted of Ms. Catherine Coste, Dr. Jane Emerson and Dr. Mark Sirgo, with Ms. Catherine Coste serving as Chairperson of the Audit Committee. It is anticipated that Dr. Jane Emerson will continue to serve on the Audit Committee after the Annual Meeting. ... The following table presents the compensation of non-employee directors for the fiscal year ended May 31, 2022. Jane Emerson, M.D., Ph.D. ... Total Value ($) 141,523 |
| 2023-09-27 |
The following table sets forth the name and current age of each director nominee, the year he or she was first elected, and his or her position(s) with the Company... Jane Emerson, M.D., Ph.D. 68 2007 Director, Member of Nominating & Governance Committee and Compensation Committees... The following table presents the compensation of non-employee directors for the fiscal year ended May 31, 2023... Jane Emerson, M.D., Ph.D. 45,000 fees earned or paid in cash, 0 stock awards, 87,773 option awards value, 0 non-equity incentive plan compensation, 0 change in pension value, 7,500 all other compensation, total 140,273. |
| 2024-09-30 |
Dr. Jane Emerson has served as a Director of the Company since April 2007. |
|